Table 3.

(a) P-values (b) Pearson r-values for correlations between half-life, progression-free survival, FNuct levels (measured as FNuct/peak 5FU) and fractional metastasis signal in the patient group with liver metastatic disease

	Half-life	PFS	FNuct	FMS
a
Half-life		0.17	0.016	0.25
PFS	0.17		0.14	0.38
FNuct	0.016	0.14		0.09
FMS	0.25	0.38	0.09
b
Half-life		−0.38	0.61	0.40
PFS	−0.38		−0.40	−0.32
FNuct	0.61	−0.40		0.56
FMS	0.40	−0.32	0.56